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The study shows how nanotechnology evolves in developed countries and Brazil, raising aspects of 
private and governmental initiatives. The investigation was based in scientific literature, electronic 
articles and conference reports. Several sources of literature were used, including electronic databases 
and reference lists. By this study, it was observed that, although nanotechnology is in initial stage of 
development all over the world, the developed countries have had growing public and private investments 
in the area each year. In those countries, there is a concern toward both, the formation of specialists in 
nanotechnology and the transference of technology developed in universities and research institutes to 
industry. In Brazil, the study showed that despite the growing concern of investigators, national research 
centers and financial centers toward the development of the nanotechnology, there is still a need for more 
investment and formation of area specialists.
Uniterms: Nanotechnology/development. Nanobiotechnology. Nanopharmaceutical.
O presente trabalho faz um estudo sobre o desenvolvimento da nanotecnologia, com enfoque na área 
de saúde, em países tecnologicamente mais avançados e no Brasil, levantando aspectos de iniciativas 
governamentais e privadas. A investigação foi baseada em literatura científica, artigos eletrônicos e 
relatórios de conferências. Foi observado que, apesar da nanotecnologia estar em estágio inicial no mundo 
inteiro, os países tecnologicamente mais avançados têm tido investimentos crescentes na área a cada ano, 
tanto públicos quanto privados. Há grande preocupação nesses países quanto à formação de profissionais 
especialistas na área e à transferência da tecnologia desenvolvida por universidades e institutos de pesquisa 
para a indústria. No Brasil, o estudo mostrou que apesar da crescente preocupação dos pesquisadores, 
centros de pesquisa e centros de financiamento com o desenvolvimento da nanotecnologia, ainda há 
necessidade de maiores investimentos e formação de profissionais especialistas na área. 
Unitermos: Nanotecnologia/desenvolvimento. Nanobiotecnologia. Nanofármaco. 
INTRODUCTION
The nanotechnology is nowadays an emerging te-
chnology; no more just a vision for future, as it was seen 
at the end of 20th century, with potential to impact every 
aspect of modern human civilization. The more diverse 
areas will be affected, such as agriculture, communication, 
energy generation/transmission, informatics, environmen-
tal monitoring, food manufacturing/processing, health, 
personal care, astronautics, robotics, but probably the 
strongest impact will be in medicine (Roszeki, De Jonga, 
Geertsma, 2005).
The nanotechnology is currently one of the main 
focuses of Science, Technology and Innovation (C&T&I) 
activities in all industrialized countries. The investments 
in the area have been growing and achieved worldwide 
five billion dollars in 2002. There are estimates that from 
2010 to 2015, the world market for industrial materials, 
products and processes based on nanotechnology will be 
of one trillion dollars. This voluminous production will be 
distributed over practically all economics sectors, because 
the nanotechnology will affect a great number of industrial 
products and processes, in all areas, besides creating new 
service activities (Dos Anjos, Tavares, Mendes, 2004).
Beyond the vast industrial use of nanotechnology, 
great innovations are anticipated in medicine, having their 
predominance in diagnosis, monitoring, more durable 
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prosthesis, and new drug delivery systems. The pharma-
ceutical sector occupies the third place in the foreseen 
ranking of the largest nanotechnology markets in 2015.
When applied to biomedical sciences, such as me-
dicine and pharmaceutics, the nanotechnology receives 
the name of nanobiotechnology (Com Ciência, 2002a).
In regions of more advanced technology, such as 
USA and Europe, it is perceived a larger concern for the 
nanotechnology development. A study developed by 
the European Science Foundation shows the strengths, 
weaknesses, opportunities and threats for the development 
of such technology in the region. In terms of research, 
for instance, there are in Europe many academic groups 
leading the subdisciplines of nanobiotechnology with 
expertise in delivery systems and clinical development 
of nanodrugs. However, they face the problem of brain 
drain, with the migration of young scientists to the USA 
(European Science Foundation, 2004).
In the past Brazil used to be a mere spectator of the 
great technological advances. The change in old paradigms 
of  sciences and the technology exchange enabled by the 
world wide web have favoured Brazil and other developing 
countries (Com Ciência, 2002b). In this context, the Mi-
nistry of Science and Technology (Ministério da Ciência 
e Tecnologia - MCT)/National Council of Scientific and 
Technological Development (Conselho Nacional de Desen-
volvimento Científico e Tecnológico - CNPq) has taken the 
initiative and created in 2003, the General Coordination of 
Nanotechnology. Besides, it has created a multidisciplinary 
and multisectorial work group (Grupo de Trabalho – GT) to 
elaborate a national program of Research and Development 
(R&D) in Nanosciences and Nanotechnologies (N&N), 
identifying the real needs to foster the development of nano-
technology in Brazil to enable the country to be competitive 
in the international market.
There is currently a significant scientific production 
in Brazil, with great number of university laboratories 
investigating the area of nanotechnology (Galembeck, 
2005), in themes such as nanoobjects manipulation, na-
noelectronics, nanobiotechnology, which includes nano-
drugs, nanocatalysis and the nanocomposites (Dos Anjos, 
Tavares, Mendes, 2004).
This present work makes an analysis about how na-
notechnology is being developed in more technologically 
advanced countries and in Brazil as well, focusing as much 
as possible on health, and raising aspects of governmental 
and private initiatives.
This investigation was based on scientific literature, 
electronic articles and conference reports. The literature 
was identified from several sources, including electronic 
databases and reference lists.
DEVELOPMENT OF NANOTECHNOLOGY IN 
ADVANCED COUNTRIES
The nanotechnology is still in initial phase of develo-
pment all over the world. The current role of federal funding 
for the research and development in this area is to provide 
the bases for elementary research, on which the future 
technologies of nanometric scale will be established. The 
elementary research is necessary to improve the basic un-
derstanding in several fields of science and engineering, as 
well as to provide new approaches for the synthesis, analysis 
and manufacturing of products based on nanotechnologies. 
The development of new devices enabling precise measu-
rements and manipulation within the nanometric scale is a 
current and actual challenge (Inovação, 2004). 
Challenges as such present also different opportu-
nities; for instance, to develop interdisciplinary projects 
among different agencies, leading to the merge of tradi-
tional lines of investigation and creation new ones; the op-
portunity to refresh Chemistry and Physics, bringing these 
disciplines to the dimension where singular properties of 
nanometric objects take place and, not coincidently, to the 
functioning level of biological systems; and opportunities 
to develop new engineering systems and instrumentation 
that could be used to handling and measure nanostructure 
properties, including biological systems that were few time 
ago, beyond our means.
Because of this complexity, and the high cost and 
risk associated with nanotechnological investigations, the 
private sector, frequently, is not able to assure of its own 
accord the return of investments in short or middle term 
for this specific R&D field. Consequently, it is improbable 
that the industry develops the investments in basic rese-
arch required to overcome the existing technical barriers 
(Inovação, 2004).
On the other hand, the industry is increasingly 
confident in the differentiated possibilities of this tech-
nology. Just to contextualize a little better, it is estimated 
that within 10 to 15 years the annual production of the 
nanotechnology sector should overcome the rate of one 
trillion dollars, requiring about two million employees 
(Alves, 2004). At least 30 countries have started national 
activities in this field.
The Europe, Japan and United States (USA) have the 
higher governmental investments; being that from 2001 
to 2003 Japan has invested a little more than the other two 
great actors (ETC Group, 2005). 
Table I shows the amount of governmental investi-
ments in R&D done by the major stakeholders.
There is a growing trend of nanotechnology invest-
ments all over the world. When comparing the amount 
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invested by governmental entities in 2003 with the amount 
invested in 1997, it is perceived an increase along those 
years of approximately six times. However, it is also obser-
ved an enormous gap between the amount of investments 
of West -Europe, Japan and USA,  when compared to other 
countries (including Australia, Canada, China, Eastern 
Europe, Israel, Korea, Singapore, Taiwan and remaining 
countries with nanotechnology R&D programs).
In 2004, the worldwide investment in nanotechno-
logy from private and public sectors, was estimated in 
US$ 8.6 billion (ECT Group, 2005). From that year on, 
USA started to lead the team of countries that more inten-
sively invest in this area, a leadership previously occupied 
by Japan, up to 2003. Figure 1 depicts the public and priva-
te investments done in nanotechnology R&D at EU, USA, 
Japan and other countries, in the year of 2004.
It is interesting to observe that in USA and Japan, 
which are the countries with higher investments in nano-
technology, the larger part of investments comes from the 
private sector. However, in general, the public investments 
are higher than the private ones, in the major part of the 
world.
TABLE I – R&D governmental investments in nanotechnology, 2000-2003
Region Approximate amount invested (million dollars/year)
2000 2001 2002 2003
Europe 200 ~225 ~400 ~600
Japan 245 ~465 ~700 ~810
United States 270 422 697 774
Others* 110 ~380 ~550 ~800
Total 825 1492 2347 2984
% 1997 191% 346% 502% 690%
* Other includes Australia, Canada, China, Eastern Europe, Israel, Korea, Singapore, Taiwan and remaining countries with 
nanotechnology R&D programs. Source: Alves, 2004.
FIGURE 1 - Public and private investments in nanotechnology R&D, in the year of 2004. Source: UNIT G4, 2005.
Investments in R&D (in million of Euros)
Private; State members + associated; European Community 
Private; States; Federal
Private; Public
Private; Public
European Union, USA, Japan, Other
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United States
In the last three years, the nanotechnology has 
firmed itself as one of the priorities for the American 
investments. It started to receive higher attention during 
the government of President Bill Clinton, in the 90s, due 
to endeavor from that time Vice-President Al Gore (Com 
Ciência, 2002c). In 2001, the American government has 
created a great program named National Nanotechnology 
Initiative (NNI), with the purpose to coordinate the R&D 
of nanoscale science, engineering and technology (The 
National Nanotechnology Initiative, 2004). Nowadays 25 
agencies are part of that program, being that 13 of them 
invest in R&D of nanotechnology (The National Nano-
technology Initiative, 2006). Among these agencies are: 
National Aeronautics and Space Administration (NASA), 
National Institute for Occupational Safety and Health 
(NIOSH), National Institutes of Health (NIH), National 
Science Foundation (NSF), Food and Drug Administra-
tion (FDA), U.S. Patent and Trademark Office (USPTO, 
Department of Commerce), and others (The National 
Nanotechnology Initiative, 2004).
The investigation agenda for the agencies parti-
cipating of NNI is coordinated by the Subcommittee of 
Nanoscience and Nanoengineering (Nanoscale Science 
and Engineering Technology - NSET) of the National 
Science and Technology Council (NSTC). The NSTC 
is an interagency organism of ministerial level, through 
which the science and technology themes from agencies 
are discussed and coordinated. The NSET is formed by 
representatives from participant agencies, the Office of 
Science and Technology Policy (OSTP) and of Office 
of Management and Budget (OMB). The Subcommittee 
includes also other federal agencies that do not fund 
Nanotechnology R&D, but have interest in these tech-
nologies – such as FDA and the Treasure Department. 
The members of NSET meet once a month to evaluate 
the progress, establish priorities, organize work meetings 
and plan the following year.
The funding for NNI supports an ample extent of 
activities, such as basic research, which concentrates 
efforts to answer questions of great significance, the so 
called “Great Challenges”; as well as the construction 
of research infrastructure (instrumentation, equipment, 
facilities), excellence centers and network (larger and cen-
tralized facilities, with the purpose to provide spaces for 
cooperative and collaborative efforts between investigator 
networks and groups in the many affiliated institutions). 
Depending on the agency, the fund supports investigation 
oriented to specific internal missions, research in natio-
nal laboratories, academic or other institutions. Part of 
the funding is also addressed to approach non-technical 
research problems in a broader context, including social 
implications and staff training (Inovação, 2004).
The targets of NNI are: a) advance a world-class 
nanotechnology research and development program; b) 
foster the transfer of new technologies into products for 
commercial and public benefit; c) develop and sustain 
educational resources, a skilled workforce, and the suppor-
ting infrastructure and tools to advance nanotechnology; 
d) support responsible development of nanotechnology.
The investments from USA government in the area 
of nanoscience and nanotechnology (N&N) are progres-
sively increasing every year (Table 1). The budget for the 
year of 2006 had an increase of 8.3% when compared to 
2005. For 2007, the budget was 1.3 billion dollars (Bud-
get, 2007).
The NNI aroused also the interest from regional, 
state and local authorities to invest in this area. These 
authorities aim to obtain the economical benefits from 
research in nanotechnology, as well as its commerciali-
zation. It is estimated that these investments attain a total 
of 20% of federal investments. As presented at Figure 1, 
the private sector is also investing in R&D, in an equal or 
higher level than federal government.
This entire policy has the purpose to maintain the 
American position on the top of the list of new technologi-
cal discoveries (The National Nanotechnology Initiative, 
2004).
The investment strategy of NNI is done through ma-
jor subject areas, the so called Program Component Areas 
(PCAs). The Program Component Areas are: a) fundamen-
tal nanoscale phenomena and process; b) nanomaterials; 
c) nanoscale devices and systems; d) instrumentation 
research, metrology, and standards for nanotechnology; 
e) nanomanufacturing; f) major research facilities and 
instrumentation acquisition; g) social dimensions. Every 
PCA may include researches varying from the basic to 
applied, as well as the development of applications based 
in nanotechnology.
Because they are quite recent, newer than 10 ye-
ars, the investments and researches in N&N in the USA, 
summing private and public resources, have not reached 
the same amount of resources as the Genome Project, for 
instance; which is treated as a priority. The expectation 
for the future of N&N is that it achieves the same status 
of genetics, because with its multidisciplinary character, 
it embraces areas from the Genome Project itself. In this 
phase of “advertising”, the N&N is being assimilated by 
the society. A majority of experiments is still in phase of 
tests, but the conception of N&N has already ample di-
vulgence. The maturing time for the practical applications 
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varies according the research area. The nanotechnology 
of materials for the production of polymers, for instance, 
should arrive to market in one or two years, while the te-
chnology for electronics and drugs should wait five years 
more to have practical applications (Com Ciência, 2002 c).
The hard disposition from the United States to 
effectively invest in the area “catalyzed” a reaction from 
European Community countries and Japan, initially, and 
from other countries, lately, leading to the assemblage 
of many other ambitious national programs, based on 
the acknowledge that nanotechnology would be of large 
importance within a close future for industrialized nations 
and for those countries “on the course of” becoming in-
dustrialized (Alves, 2004).
Japan
The application of nanotechnology into biomedical 
areas, including the diagnosis, pharmaceutical products and 
related areas, was strongly emphasized in the national pro-
grams/initiatives of nanotechnology in Asian countries. The 
government has put efforts to coordinate national programs 
and promote interdisciplinary collaborations. In Japan, 
Korea and Taiwan, the fusion of information technology, 
biotechnology and nanotechnology is particularly explicit 
in their specific policies of Science and Technology. The 
projects related to nanotechnology in Asia, including China, 
Japan, Korea and Taiwan, cover topics such as diagnosis 
(molecular detection including biochips, “lab-on-a-chip”, 
proteinic chips, sensors, genetic therepy and imaging), drug 
delivery systems (DDS), regenerative medicine (stem-cells 
and tissue engineering) and medical devices.
The Japanese government and companies have en-
gaged themselves to promote the research, development 
and market of nanotechnology. The Third Basic Plan of 
Science and Technology (2005) emphasized five main stra-
tegies for the next five years of Science and Technology 
development in the country. The five strategic areas are: 1. 
Strategy of Human Resources, including the creation of a 
diversified and integrated education program, encouraging 
women, utilizing the expertise from seniors and importing 
excellent foreign scientists to Japan; 2. Strategy of Fun-
damental Research, with the purpose to diversify areas of 
fundamental research, assuring the allocation of compe-
titive funding in these areas at universities and enforcing 
infrastructures; 3. Strategy of Innovation, focused in four 
prioritized areas including Biotechnology, Environmental 
Technology, Nanotechnology and Informatics and their fu-
sion areas, in order to create social and economical values 
for the innovations, assuring the commercialization of the 
original research results and reinforcing the cooperation 
among industry-government-academy; 4. Strategy of 
Basic Nucleus Technology, that develops the characte-
ristic nucleus of national nanotechnology, to assure long 
term and sustainable development to areas of integrated 
Earth observation and monitoring systems in global scale, 
spatial transportation systems, petaflop supercomputer, 
high speed protein factory and others; 5. International 
Strategy, promoting international activities including 
the establishment of an attractive research environment, 
importing excellent foreign human resources, enforcing 
the dissemination of information and taking the lead to 
establish the Eastern Asia Community (Asia, 2005a). 
The government funding agencies have worked 
close to companies, as well as R&D communities, to 
understand the status of national and international deve-
lopment and the Japanese companies competitiveness in 
several sectors in which nanotechnology is relevant, es-
pecially the areas of Information Technology/Electronics, 
Environment/Energy/Fuel Cells, Metrology, Precision 
Engineering/Advanced Manufacturing, Space, Materials/
Advanced Coatings and Biomedical and Health Care 
(Asia, 2005b). The last one has become one of the greatest 
application targets of Japanese nanotechnology.
In Japan, besides the advanced manufacturing 
technologies for Japanese companies, another target of 
nanotechnology is its application on the improvement 
of population health. The nanobiotechnology has trans-
formed itself into a priority within the Japanese policy 
of Science and Technology. The government started a 
coordinated effort in 2003, following a study conducted 
by the Ministry of Economy, Trade and Industry (METI) 
about nanobiotechnology trends and their application 
in industry. The METI has immediately launched diffe-
rent nanobiotechnological projects under the ‘Focused 
21 Program’ conducted by Japanese companies such as 
Olympus, Toray, NEC, Shimazu and others. The projects 
had duration of four years (2003 - 2006), with investments 
varying from 1.4 to 17.1 million dollars only for the year 
of 2005 (Asia, 2005c).
To promote even more the nanobiotechnology com-
panies in Japan, the METI has established the ‘NanoBio 
Working Group and Industry Committee’ to investigate 
the status of nanobiotechnology industry in Japan and 
foreign parts, and to formulate the map in collaboration 
with Japanese companies, universities and national insti-
tutions, as well as the “think-tank” organizations, such as 
the Mitsubishi Institute of Research. The Ministry of Edu-
cation, Sports, Culture, Science and Technology (MEXT) 
gives priority also to nanobiotechnology in its policy of 
science and technology. The nanobiotechnology projects 
are funded under many schemes, including the ‘Science 
C. F. Rediguieri194
and Research Grant Assistance’, ‘21st Century Center 
of Excellence’ (COE) and the ‘Science and Technology 
Promotion Funds’. In particular, the COE is a program of 
five years with the budget between 1 – 5 million dollars 
per year per project.
In Japan, more than 80% of nanotechnology com-
panies actively conducting R&D and Nanotechnology 
business are great companies, with more than 10 million 
dollars of capital and more than 1000 employees. The Ja-
panese understand that nanotechnology requires expensive 
long term investments in infrastructure and R&D, in order 
to achieve the commercialization stage, which is obviou-
sly more difficult to small and middle companies (less 
than 300 employees and capital lower than three million 
dollars) than to larger companies (Asia, 2005d).
Since 2000, the investment in nanobiotechnological 
areas, such as drugs delivery systems (DDS), and applica-
tions of nanomaterials, such as the carbon nanotubes, are 
becoming popular. In 2001, a great number of corporations 
in Japan have created a nanotechnology fund dedicated 
to business and R&D in this area. The two largest ones, 
Mitsubishi Corporation and Mitsui & Co, launched a fund 
of 150 million dollars for the development of business in 
nanotechnology for five years (Asia, 2005e).
Despite the Japanese government impelling to 
a stronger industry-government-university collabo-
ration, the challenges remain, such as the ownership 
of intellectual property, the sufficient comprehension 
of mutual objectives and the development objectives 
(Asia, 2005d). The nanotechnology is still in the basic 
research phase and in the level of research and develo-
pment of products.
Experts of the area have done recommendations to 
Japanese politicians respecting to improvement and cons-
truction of infrastructures or establishment of new systems 
to accelerate the nanotechnology commercialization, in 
order to improve the competitiveness of Japanese R&D 
and industry.
European Union
Europe is one of the leading actors in nanoscience 
and nanotechnology in strict research and in technologi-
cal development, thanks to its investigators’ creativity; 
to initiatives from its industry, universities and research 
organizations; to its quality infrastructure and to the com-
mitment of its public authorities. During the last two de-
cades, the European Union (EU), through the ‘Framework 
Programmes’ (FP), has had a support policy to science and 
technology targeting essentially the incentive for coope-
ration between European investigators.
In 2000 March, the European Council of Lis-
bon adopted the European Research Area (ERA), 
establishing the foundation for a common science and 
technology policy through European Union (European 
Commission, 2007).
During the EuroNanoForum 2003 occurred in Tries-
te, Italy, with more than a thousand participants, it was 
formed the conception of an integrated and responsible 
action in nanotechnology. This was followed by the publi-
cation of a communicate “Towards an European Strategy 
of Nanotechnology” by the European Commission in May 
2004 (Nanoforum, 2004a).
Including the visions from various interested parts, 
this integrated and responsible strategy has highlighted 
the necessity of conjunct actions in:
-  increasing the investments and coordination of R&D 
to reinforce the industrial exploration of N&N toge-
ther with excellence and scientific competition;
-  developing a worldwide competitive infrastructure 
of R&D (“poles of excellence”) that takes into ac-
count the necessities coming from the industry, as 
well as those from the research organizations;
-  promoting the education and interdisciplinary 
training of investigators together with a stronger 
enterprising mentality;
-  promoting favorable conditions for industrial inno-
vation, in order to assure that R&D are translated 
into accessible and safe products and processes for 
wealth creation;
-  respecting ethical principles, integrating social con-
siderations in the R&D process in its initial stage and 
encouraging the dialog with citizens;
-  directing the public health to safety and occupational 
health, environmental risks and those of consumers 
of products based in N&N in the initial stage;
-  complementing the above actions with appropriate 
cooperation and initiatives at international level 
(Tomellini, Monk, 2005).
On September 24th, 2004, the Competitiveness 
Council has published a report about its conclusions 
respecting to nanotechnology. In this report, the Coun-
cil recognizes the importance of N&N in several areas; 
remembers the strategy of creation of ERA (European 
Research Area); endorses the integrated and responsi-
ble strategy of communication “Towards an European 
Strategy of Nanotechnology”; and accepts the intension 
of European Commission to develop a Plan of Action 
during the first quarter of 2005, after a great discussion 
with the several interested parts and engaging itself in an 
international level dialog, with the vision of establish a 
structure of shared principles for the development and use 
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of nanotechnology in a safe, maintainable, responsible and 
social way (Council, 2004).
Nowadays, the majority of European countries have 
the projects or initiatives sponsored by EU. Among them 
there are the European Framework Programmes (FP), 
with are programs projected to reinforce and expand the 
research and development in Europe (Nanoforum, 2004b).
Based on the Accord that established the European 
Union, the FP have to follow two main strategic objec-
tives: to reinforce the scientific and technologic bases 
of industry and to encourage the international competi-
tiveness, while promoting research activities to support 
other EU policies. The FPs are the main tool of EU for 
the funding of research in Europe, being proposed by 
European Commission and adopted by the Council and 
by European Parliament through a process of conjunct 
decision. The FPs have been implemented in 1984 and 
every FP comprehends a period of five years, including 
the last year of previous FP and the first year of follo-
wing FP. Between the prioritized areas of sixth FP (FP6), 
which was in force between 2002 and 2006, were those 
of “Nanotechnology and nanoscience, Multifunctional 
materials based on knowledge and New processes and 
production artifices” – NMP (Cordis, 2007a).
The Figure 2 shows the areas of higher governmental 
investment in nanotechnology at EU. The fourth FP (FP4) 
was in force between 1994 and 1998, and the fifth FP 
(FP5), from 1998 to 2002. The percentage of investments 
in nanobiotechnology has grown between one FP and the 
following one.
With budged of € 1,429 million for 2002 – 2006, 
the priority of NMP (Nanosciences Nanotechnologies, 
Materials, Processes) within the FP6 was to promote the 
transition toward “knowledge-based” products and servi-
ces, with the discovery of new applicable knowledge in 
the long term (Cordis, 2007b).
The governmental support for the research in N&N 
has recently increased in all countries. The average rates 
of yearly growth differ from -10% in Denmark to +55% 
in Italy and 213% in Ireland. The accentuated increase in 
Ireland was caused by the launch of a special program of 
nanotechnology in 2000. For Europe, as a total, the average 
rate yearly growth is of 12% (European Commission, 2003).
A report of 2004 from the European Science Foun-
dation suggests that these funding mechanisms are not 
adequate for the development of nanobiotechnology. The 
programs structure and the diversity of funding sources 
(for instance, from European Union, national, regional 
and other entities) make the path to funding more sinuous. 
Another limiting factor is the fact that many resources are 
given for the traditional scientific disciplines, which could 
exclude interdisciplinary researches or those with many 
interfaces. In many cases, the funding is restrained because 
the project requires a partnership with the industry. There 
are also some cases in which the selection criteria could be 
political, instead of based on scientific excellence.
FIGURE 2 – Areas of R&D in Nanotechnology supported by successive FPs. Source: Unit G4, 2005.
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DEVELOPMENT OF NANOTECHNOLOGY IN 
BRAZIL
The concern for this new technology in Brazil has 
concretized itself with the establishment of the Program of 
Development of Nanotechnology and Nanoscience within 
the Pluriannual Plan of 2004 – 2007, whose bases were 
given by the proposal of the Work Group (GT) created 
by Ordinance MCT-252 of 2003. The government has 
elected, from that occasion on, the Nanotechnology and 
Biotechnology as focuses of its policies for the industrial 
development. Such areas were identified as those that will 
bring a new technological revolution, accompanying an 
international movement in the main countries of techno-
logical development (Instituto, 2005).
The initiative has emerged from the need to create 
an ample program for research and development in nano-
technology, maximizing the existing resources utilization, 
creating and reinforcing similar laboratories, capacitating 
and training human resources, integrating the competences 
in the area and supporting the competitiveness of different 
segments of industry (Ministério, 2004).
This interministerial program, captained by MCT 
(Ministério da Ciência e Tecnologia) and involving 
different public and private institutions, focuses on the 
research and development, the creation of human capacity 
(developing new talents), the provision of infrastructure 
(laboratories, etc.) as well as the study of potentialities for 
commercialization and innovation. The public and private 
Institutions that participate in the Program of Development 
of Nanotechnology and Nanoscience are: Ministry of 
Science and Technology (providing resources for R&D 
from CNPq and FINEP), Ministry of Development, In-
dustry and Foreign Commerce (through its organs: INPI, 
BNDES, INMETRO), Ministry of Education (involve in 
the CAPES), Ministry of Health (with the DECIT, FIO-
CRUZ, ANVISA), Ministry of Agriculture, Livestock and 
Supplying (through the EMBRAPA), Ministry of Defense 
(with the technological centers of Aeronautics, Army and 
Marine), CNI (Confederação Nacional da Indústria or 
National Confederation of Industry), SENAI (Serviço 
Nacional de Aprendizagem Industrial or National Service 
of Industrial Apprenticeship) and SEBRAE (Serviços de 
Apoio às Micro e Pequenas Empresas or Service of Sup-
port to Micro and Small Companies). 
The purpose of the program is to create and develop 
new products and processes in nanotechnology to increase 
the competitiveness of national industry; and to capacitate 
personnel for the utilization of the economic, technological 
and scientific opportunities of nanotechnology (Ministé-
rio, 2004).
To achieve the aforementioned objectives, the pro-
gram aims:
-  To establish clear and objective policies, which 
create a favorable investment environment;
-  To provide the necessary long term resources for the 
constitution of capacities;
- To establish a regulatory structure to assure the social 
welfare and the competitiveness;
- To encourage other agents to conjunct public-private 
partnerships in the development of products and 
processes (Instituto, 2005).
The GT has presented in its project the following 
budgetary demands for resources from the national treasure 
and/or other sources, including the Sectorial Funds, neces-
sary for the execution of the Program, presented at Table II.
To these resources should be summed resources 
from companies and state or regional organs, especially for 
the activities of research and development in nanoscience 
and nanotechnology.
The functioning form of the program was thought 
to operate in networks. Initially, the proposal elaborated 
by GT anticipated the structuring of six networks, being 
that four were already in operation (Nanobiotechnology 
Network, Nanostructured Materials and Thin Films Net-
work, Nanodevices and Semiconductor Materials Network 
and Molecular Nanotechnology and Interfaces Network), 
TABLE II – Budgetary demands for the Program of Development of Nanotechnology and Nanoscience
Item Budgetary demands (thousand reais/year)
2004 2005 2006 2007 Total
Implantation of laboratories and nanotechnology networks 71.130 71.130 71.130 71.130 284.520
Support to networks and nanotechnology laboratories 3.720 5.999 9.012 11.278 30.000
Program management 350 350 350 350 1.400
R&D in nanoscience and nanotechnology 21.500 21.500 21.500 21.500 86.000
Total 96.700 98.970 101.992 104.258 401.920
Source: Ministério da Ciência e Tecnologia, 2004
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being then necessary to create two new networks (Nano-
analysis and Diagnosis Network and Nanometrology and 
Instrumentation Network).
Among the networks supported by the program, 
the one that has direct application to health area was the 
Nanobiotechnology Network, coordinated by UNICAMP/
UMC (Universidade Estadual de Campinas/Universidade 
de Mogi das Cruzes) from 2001 up to 2004. 
The goals of the Nanotechnology Network were the 
technological development and innovation for foreign com-
petition; to execute research, development and innovation 
projects favoring the interaction between laboratories and 
companies, as well as favoring the value and technology 
aggregation into industrial products. The targets consist, in 
short term, in the identification of companies with affinity 
for nanobiotechnology; the establishment of partnership 
between companies and laboratories; the proposal of mana-
gement models and administrative structure for the network; 
and, in long term, the attraction of companies and investors 
for nanobiotechnology projects and supporting the creation 
of innovative companies (Ministério, 2007). 
This network has produced a total of 713 publica-
tions and has obtained 25 approved patents from 2001 
to 2003. Some examples of projects already developed 
by the network and whose products were passed to the 
industry are:
- PROJECT: “Encapsulation of antihypertensive in 
cyclodextrins” (UFMG). Company: BIOLAB FAR-
MACÊUTICA S.A. The company acquires from 
UFMG the right to produce antihypertensive with 
the technique of controlled release of drug;
- PROJECT: “Biosensors for determination of coffee 
quality” (EMBRAPA). Company: ASSOCIAÇÃO 
BRASILEIRA DAS INDÚSTRIAS DO CAFÉ 
(ABIC);
- PROJECT: “Utilization of immunemodulator in 
immunodepressed patients/animals” (UMC/UNI-
CAMP). Company: BIOLAB FARMACÊUTICA 
S.A. (Rede, 2003).
On August 19th, 2005, it was launched the National 
Program of Nanotechnology (Programa Nacional de 
Nanotecnologia – PNN) by President Luiz Inácio Lula 
da Silva and by the Minister of Science and Technology, 
Sérgio Rezende, during a visit to the National Laboratory 
of Sincrotron Light (Laboratório Nacional de Luz Síncro-
tron – LNLS), in Campinas-SP, an organ linked to Ministry 
of Science and Technology (MCT). The PNN, composed 
by a conjunction of actions supported by budgetary re-
sources from the 2004 – 2007 PPA (Plano Plurianual or 
Pluriannual Plan) and Sectorial Funds, has the purpose to 
meet the strategic demands identified by the community 
involved with the nanoscience and nanotechnology deve-
lopment and to put into practice one of the measures of the 
Industrial, Technological and Foreign Commerce Policy 
(Política Industrial, Tecnológica e de Comércio Exterior 
– PITCE) (Ministério do Desenvolvimento, Indústria e 
Comércio Exterior, 2008).
With the publication of the Edictal MCT/CNPq 
29/2005, the existing networks were restructured and new 
networks were created. According to the Reporting Refer-
ring to Management of Program “Development of Nanos-
cience and Nanotechnology” in the Assignment of 2005, 
which was elaborated by the Secretariat of Technological 
Development and Innovation of the Ministry of Science 
and Technology, there are ten nanotechnology networks 
being supported by the program: Simulation and Modeling 
of Nanobiostructures (USP); Network of Nanophotonics 
(UFPE); National Network of Nanobiotechnology and Na-
nostructured Systems – Nanobiostructures (UFRN); Coo-
perative Network of Research in Nanostructured Coatings 
(PUC/RJ); Probes Scanning Microscopy – Open Software 
and Hardware (LNLS); Carbon Nanotubes: Science and 
Applications (UFMG); Nanoglucobiotechnology (UFPR); 
Molecular Nanotechnology and Interfaces Network – Sta-
ge I, II (UFPE); Nanobiomagnetism Network (UNB), and 
Nanocosmetics: from the Conception to Technological 
Applications (UFRGS). These networks are at initial phase 
of execution and their activities are concentrated in the 
equipment acquisition, integration and implementation of 
adequate infrastructure (Ministério, 2005). 
In the new structure, the nanobiotechnology is 
coordinated by Federal University of Rio Grande do Norte. 
Until the present moment, consolidated reports about the 
performance of this network, containing the total number 
of teachers and post-graduation students involved in re-
search projects from the nanobiotechnology network, as 
well as the total number of published articles and granted 
patents, are not yet available.
Entities from all over the country are part of the 
nanotechnology networks; however, there is a lower 
concentration of projects from the northern and central-
western region. According to results from the last edictal of 
National Council of Scientific and Technological Develo-
pment (Conselho Nacional de Desenvolvimento Científico 
e Tecnológico – CNPq) referring to public selection of 
research project proposals, presented by young investi-
gators for funding of research and development activities 
in Nanoscience and Nanotechnology (Edital FVA/MCT/
CNPq nº 09/2007), out of 45 approved projects, only 4 
were from the central-western and northern region (two 
of every region). This difference can also be observed in 
the edictal of public selection of research and development 
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project proposals turned to improvement of laboratory 
infrastructure in nanotechnology: out of 12 approved pro-
posals, 7 were from southwestern region, 3 from southern 
region, 2 from northeastern region and none proposal from 
northern or central-western region (Conselho, 2007a, b). 
This shows the evident correlation between the regional 
technological-scientific development and the organization 
of nanotechnology networks in the country.
CONCLUSIONS
As reported, the nanotechnology is still in its initial 
phase of development all over the world. However, it is 
already established that its contribution in all areas of 
knowledge will enormously increase in the very near future.
The nanotechnology will bring many economic 
opportunities for the countries that invest in C&T&I. 
Because of that, the investments trend in this area is 
progressively growing all over the world. One of the 
major impacts of nanotechnology will be in health, 
more specifically in the pharmaceutical field, with the 
development of nanodrugs.
It was observed that in countries of more advanced 
technology, such as USA, Japan and EU, the investments 
in nanotechnology from both private and public sources 
are growing year by year.
This new technology is creating a natural dominium 
of interdisciplinary interactions and triggering a revision 
in the universities curricular frames, creating new 
educational paradigms. There is great concern regarding 
the formation of professional experts in the area and the 
translation of technology developed by universities 
and research institutes to industry. It was noticed that 
the European Union is facing a problem of evasion of 
nanotechnology expert investigators to the USA.
In Brazil, the study has shown that despite the 
growing concern of investigators and national research 
or funding centers with nanotechnology investigation, 
larger investments and formation of expert professionals 
in the area are still needed. Government and private sectors 
should invest more in nanotechnology R&D. Another 
observed problem is that nanotechnology investments 
in Brazil are excessively concentrated, essentially, in 
the southwestern region. For a larger advancement in 
this area, it is important to involve all country regions 
in this entrepreneurship, mainly the regions of lower 
technological development, such as northern and central-
western country.
The experience from countries of more advanced 
technology could be transformed in excellent example for 
Brazil, by utilizing the positive aspects and potentialities 
of such programs, and avoiding some of their mistakes 
and deficiencies.
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